Business Description
WPD Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA95753W1086
Compare
Compare
Traded in other countries / regions
WBIO.Canada8SV1.GermanyWPDPF.USA IPO Date
2008-05-26Description
WPD Pharmaceuticals Inc is a biotechnology research and development company. It focuses on oncology, virology, research, and development of medicinal products involving biological compounds and small molecules.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.51 | |||||
| Equity-to-Asset | -3.14 | |||||
| Debt-to-Equity | -0.42 | |||||
| Debt-to-EBITDA | -1.6 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.36 | |||||
| Quick Ratio | 0.36 | |||||
| Cash Ratio | 0.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -246.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -107.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -26.52 | |||||
| EV-to-EBITDA | -26.97 | |||||
| EV-to-FCF | -32.25 | |||||
| Earnings Yield (Greenblatt) % | -3.77 | |||||
| FCF Yield % | -2.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
WPD Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | |||
| EPS (TTM) (C$) | -0.002 | ||
| Beta | -0.1 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (C$) | 0 | ||
| 20-Day SMA (C$) | 0.045 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (C$) | 0.045 - 0.045 | ||
| Shares Outstanding (Mil) | 113.44 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
WPD Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
WPD Pharmaceuticals Inc Stock Events
| Event | Date | Price(C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
WPD Pharmaceuticals Inc Frequently Asked Questions
What is WPD Pharmaceuticals Inc(XCNQ:WBIO)'s stock price today?
The current price of XCNQ:WBIO is C$0.05. The 52 week high of XCNQ:WBIO is C$0.05 and 52 week low is C$0.05.
When is next earnings date of WPD Pharmaceuticals Inc(XCNQ:WBIO)?
The next earnings date of WPD Pharmaceuticals Inc(XCNQ:WBIO) is .
Does WPD Pharmaceuticals Inc(XCNQ:WBIO) pay dividends? If so, how much?
WPD Pharmaceuticals Inc(XCNQ:WBIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers